IL17 has been shown to exacerbate the inflammatory responses in sepsis, bronchopulmonary dysplasia, patent ductus arteriosus, necrotizing enterocolitis and brain injury.35 This evidence concerns the gene IL17A and bronchopulmonary dysplasia.